Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

297 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[A case of eosinophilic gastroenteritis caused after the use of Seprafilm®].
Kinomoto T, Yamada T, Wakahara Y, Kurahashi T, Kusumoto Y, Yamaguchi T, Sueyoshi Y, Hirao M, Hosui A, Hiramatsu N. Kinomoto T, et al. Among authors: kurahashi t. Nihon Shokakibyo Gakkai Zasshi. 2022;119(5):459-465. doi: 10.11405/nisshoshi.119.459. Nihon Shokakibyo Gakkai Zasshi. 2022. PMID: 35545545 Japanese.
Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis.
Mizutani N, Hikita H, Saito Y, Myojin Y, Sato K, Urabe M, Kurahashi T, Shiode Y, Sakane S, Murai K, Nozaki Y, Kodama T, Sakamori R, Yoshida Y, Tatsumi T, Takehara T. Mizutani N, et al. Among authors: kurahashi t. Am J Physiol Gastrointest Liver Physiol. 2021 Jun 1;320(6):G958-G968. doi: 10.1152/ajpgi.00370.2020. Epub 2021 Mar 31. Am J Physiol Gastrointest Liver Physiol. 2021. PMID: 33787344 Free article.
Exacerbation of non-steroidal anti-inflammatory drug-induced enteropathy in C-C chemokine receptor type 7-deficient mice.
Yamaguchi T, Iijima H, Yoshihara T, Tani M, Otake Y, Iwatani S, Amano T, Tashiro T, Kurahashi T, Inoue T, Tsujii Y, Hayashi Y, Inoue T, Motooka D, Nakamura S, Shinzaki S, Takehara T. Yamaguchi T, et al. Among authors: kurahashi t. J Gastroenterol Hepatol. 2022 Aug;37(8):1561-1570. doi: 10.1111/jgh.15868. Epub 2022 Apr 28. J Gastroenterol Hepatol. 2022. PMID: 35435994
Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma.
Egawa M, Yoshida Y, Ogura S, Kurahashi T, Kizu T, Furuta K, Kamada Y, Chatani N, Hamano M, Kiso S, Hikita H, Tatsumi T, Eguchi H, Nagano H, Doki Y, Mori M, Takehara T. Egawa M, et al. Among authors: kurahashi t. Hepatol Res. 2017 Oct;47(11):1196-1205. doi: 10.1111/hepr.12854. Epub 2017 Feb 3. Hepatol Res. 2017. PMID: 28002884
Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice.
Kurahashi T, Yoshida Y, Ogura S, Egawa M, Furuta K, Hikita H, Kodama T, Sakamori R, Kiso S, Kamada Y, Wang IC, Eguchi H, Morii E, Doki Y, Mori M, Kalinichenko VV, Tatsumi T, Takehara T. Kurahashi T, et al. Cell Mol Gastroenterol Hepatol. 2020;9(3):425-446. doi: 10.1016/j.jcmgh.2019.10.008. Epub 2019 Oct 24. Cell Mol Gastroenterol Hepatol. 2020. PMID: 31669262 Free PMC article.
Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma.
Ogura S, Yoshida Y, Kurahashi T, Egawa M, Furuta K, Kiso S, Kamada Y, Hikita H, Eguchi H, Ogita H, Doki Y, Mori M, Tatsumi T, Takehara T. Ogura S, et al. Among authors: kurahashi t. Oncotarget. 2018 Apr 20;9(30):21022-21035. doi: 10.18632/oncotarget.24781. eCollection 2018 Apr 20. Oncotarget. 2018. PMID: 29765517 Free PMC article.
297 results